Antibody Therapy of Cancer
Antibody marks the cancer cell and makes it easier for the immune system to find. The monoclonal antibody drug rituximab (Rituxan) attaches to a specific protein (CD20) found only on B cells, one type of white blood cell. Certain types of lymphomas arise from these same B cells. Monoclonal antibodies can also function by attenuating hyperactive growth signals neo angiogenesis. A monoclonal antibody can be conjugated to a radioactive particle that will ensure directed delivery to the cancer cell and slow and long release of the radiation, hence maximizing chances of positive outcome and minimizing non-specific damaging exposure to radiation.
- Immuno Stimulatory Monoclonal Antibodies for Cancer Therapy
- Clinical Practice on Current Monoclonal Antibodies Cancer Therapies
- Hybridoma Technology for Production of Monoclonal Antibodies
- Radiation Induced Immunogenic Modulation to Enhance T-Cell and Monoclonal Antibody Therapy of Cancer
- Impact of Epigenetic Changes on Cervical Cancer Progression
- Skin Cancer Immunology: Profiling the Inflammatory Response
Related Conference of Antibody Therapy of Cancer
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Antibody Therapy of Cancer Conference Speakers
Recommended Sessions
- Antibody Therapy of Cancer
- Brain Tumors
- Cancer & HIV
- Cancer biomarkers
- Cancer clinical trials
- Cancer Genomics and Metabolomics
- Cancer Immunology & Immunotherapy
- Cancer micro and immuno environment
- Cancer Pharmacology
- Cancer Prognosis & Diagnosis
- Cancer Research & Cancer vaccines
- Combining Cancer Immunotherapies
- Immune checkpoint inhibitors
- Immuno-Oncology studies
- Novel Approaches in Cancer & Tumor
- Radiology and Imaging in Cancer
- Stem Cell Therapy
- Tumor biology
- Tumor Immunology
- Tumor immunotherapy research
- Tumor markers and drug targeting
- Tumors
- Types of cancer
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)